HOME >> MEDICINE >> NEWS
GroPep completes final milestone of the path malaria vaccine initiative

Adelaide biotechnology company GroPep has completed the manufacture of two vaccine antigens as part of the project funded by the international PATH Malaria Vaccine Initiative (MVI).

GroPep will supply these vaccine antigens to the MVI for formulation and subsequent use in human clinical trials - expected to start in 2007.

Listed biopharmaceutical company GroPep Limited (ASX :GRO) announced today that it had successfully completed the second and final milestone of its agreement with the PATH Malaria Vaccine Initiative to manufacture malaria vaccine candidates for testing in human clinical trials.

GroPep reported the successful completion to Milestone 1 of the vaccine project in September 2003, developing scalable manufacturing processes for two malaria vaccine candidates.

Milestone 2 required scale-up of production and manufacturing to appropriate quality standards to enable the potential malaria vaccines to be tested in human safety trials. A sufficient quantity of each vaccine antigen has been manufactured.

PATH is an international, non-profit organisation that creates sustainable, culturally relevant solutions allowing global communities to break long-standing cycles of poor health. The Malaria Vaccine Initiative's (MVI) mission is to accelerate the development of malarial vaccines for the developing world. Malaria kills 7000 people each week and there is no vaccine.

MVI Director, Dr Melinda Moree congratulated GroPep on completing this important project milestone. "GroPep has made an important contribution to the quest to develop a vaccine against malaria."

GroPep's CEO, Bob Finder said that the manufacturing project had provided GroPep with a number of technical challenges that had been successfully met.

"As a Company, we are pleased to have successfully completed our part of the project, which may ultimately reduce the impact of this disease on millions of people worldwide," he said.
'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
19-Dec-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep to pursue promising asthma drug following preclinical study results
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
7. Acrux completes enrollment in key phase 2 trial
8. MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
9. Im a Kid Too project completes first phase
10. 6 finalists compete for achievement in operations research
11. Heart Rhythm Society publishes final recommendations for heart patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... April 18, 2019 , ... The Coro Medical official ... Sardis Volunteer Fire Department. , As a small, volunteer-only department in rural Mississippi, ... the community and now, is the only department with life-saving equipment of this caliber ...
(Date:4/18/2019)... , ... April 18, 2019 , ... ... its first ever Cannabis Industry Report . The study—which considers consumers’ perceptions ... intersections with retail and manufacturing, offering insight into what kinds of products consumers ...
(Date:4/17/2019)... ... 17, 2019 , ... Historically, patients have been reluctant to ... changing. Whether because of demographic or generational changes, patients seem to have become ... In the past, efforts to publish performance data about doctors and hospitals were ...
(Date:4/17/2019)... ... April 17, 2019 , ... Ramneek Kumar Talwar and Vineet ... Gwangju, Korea, and has highly evaluated and confirmed iRINGER’s technology, a product that’s ... discussion of a potential partnership since then. , After sharing relevant ...
(Date:4/17/2019)... ... April 17, 2019 , ... Purple Biosciences ... This California-made supplement was designed to lessen the negative effects of alcohol, ... purchase via GotPurpleTree.com and Amazon.com . , According to the ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... 2019 , ... KVC Kentucky will host the 2nd Annual ... horse farm on May 17, 2019 to raise funds to support KVC Kentucky’s ... elegant venue highlights Kentucky's stunning farmland, prized Thoroughbred horses and beautiful equine architecture. ...
(Date:4/17/2019)... , ... April 17, 2019 , ... Salt Lake ... Honorary Doctorate recipients. They will receive their degrees at SLCC’s May 3 Commencement at ... the executive vice president over Corporate Affairs and Miller Family Philanthropy. Richards is president ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... What do ... comedy livestream show? Hosted within the Texas Medical Center’s TMC Innovation Institute, the Healthcare ... 26th, 2019, followed by a review by potential employers — all featured in a ...
Breaking Medicine Technology:
Cached News: